Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exponent (EXPO) Cash from Financing Activities (2016 - 2025)

Historic Cash from Financing Activities for Exponent (EXPO) over the last 16 years, with Q4 2025 value amounting to -$54.5 million.

  • Exponent's Cash from Financing Activities fell 32061.12% to -$54.5 million in Q4 2025 from the same period last year, while for Oct 2025 it was -$134.3 million, marking a year-over-year decrease of 8447.51%. This contributed to the annual value of -$65.1 million for FY2025, which is 2430.09% up from last year.
  • Per Exponent's latest filing, its Cash from Financing Activities stood at -$54.5 million for Q4 2025, which was down 32061.12% from -$47.5 million recorded in Q3 2025.
  • In the past 5 years, Exponent's Cash from Financing Activities ranged from a high of -$8.8 million in Q4 2021 and a low of -$75.1 million during Q3 2022
  • Over the past 5 years, Exponent's median Cash from Financing Activities value was -$24.6 million (recorded in 2022), while the average stood at -$30.3 million.
  • Per our database at Business Quant, Exponent's Cash from Financing Activities crashed by 37918.8% in 2022 and then surged by 8315.67% in 2023.
  • Exponent's Cash from Financing Activities (Quarter) stood at -$10.0 million in 2021, then crashed by 154.54% to -$25.4 million in 2022, then increased by 21.18% to -$20.0 million in 2023, then skyrocketed by 35.32% to -$13.0 million in 2024, then crashed by 320.61% to -$54.5 million in 2025.
  • Its Cash from Financing Activities was -$54.5 million in Q4 2025, compared to -$47.5 million in Q3 2025 and -$20.0 million in Q2 2025.